MedTrace Logo

New Generation IGRA in Immunocompromised Individuals

NCT02639936 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2663

Last updated 2025-04-10

No results posted yet for this study

Summary

Evaluation of a new ELISA based interferon-gamma release assay (QuantiFERON TB plus In-tube test) in immunocompromized patients

Conditions

  • Monitoring, Immunologic
  • Active Tuberculosis
  • Tuberculosis in Solid Organ Transplant Recipients
  • Tuberculosis in Marrow Transplant Recipients
  • Tuberculosis in Rheumatoid Arthritis
  • Tuberculosis in Chronic Renal Failure
  • Tuberculosis in HIV-infected Individuals

Sponsors & Collaborators

  • Tuberculosis Network European Trialsgroup

    lead NETWORK

Principal Investigators

  • Martina Sester, PhD · Universität des Saarlandes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Denmark
  • Germany
  • Italy
  • Moldova
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02639936 on ClinicalTrials.gov